Revvity Inc. (NYSE:RVTY) Receives $107.73 Consensus Price Target from Analysts

Revvity Inc. (NYSE:RVTY) has earned a consensus recommendation of “Hold” from the fourteen research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $107.7273.

Several equities research analysts have issued reports on the company. Weiss Ratings downgraded Revvity from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 13th. TD Cowen increased their price target on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Barclays increased their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. lowered their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Finally, Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th.

Revvity Stock Up 0.8%

Shares of Revvity stock opened at $101.22 on Friday. Revvity has a 1 year low of $81.22 and a 1 year high of $118.30. The business has a 50-day moving average of $92.89 and a two-hundred day moving average of $97.41. The company has a market capitalization of $11.29 billion, a P/E ratio of 48.43, a price-to-earnings-growth ratio of 2.20 and a beta of 1.11. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. During the same period in the prior year, the company earned $1.01 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, equities analysts predict that Revvity will post 5.25 EPS for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of RVTY. AQR Capital Management LLC grew its stake in Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after purchasing an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after purchasing an additional 744 shares in the last quarter. Millennium Management LLC grew its stake in Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after purchasing an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after purchasing an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth grew its stake in Revvity by 13.0% in the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after purchasing an additional 811 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.